BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20923954)

  • 1. Use of total lymphocyte count to predict absolute CD4 count in HIV-seropositive cases.
    Gautam H; Saini S; Bhalla P; Singh T
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):292-5. PubMed ID: 20923954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total lymphocyte count and hemoglobin combined to predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/AIDS.
    Wilhan ; Budiono E
    Acta Med Indones; 2008 Apr; 40(2):59-62. PubMed ID: 19054881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of surrogate markers to predict the HIV disease stage and time to initiate antiretroviral therapy in developing countries.
    Chaudhary M; Kashyap B; Gautam H; Saini S; Bhalla P
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(5):259-64. PubMed ID: 18780895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
    Susaengrat W; Mitchai M; Leerattanapetch N
    J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
    Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
    Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis on total lymphocyte count and CD4 count of HIV-infected patients.
    Liu FR; Guo F; Ye JJ; Xiong CF; Zhou PL; Yin JG; Ye LX
    Int J Clin Pract; 2008 Jun; 62(6):955-60. PubMed ID: 17983435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
    Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M
    HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?
    Mbanya D; Assah F; Ndembi N; Kaptue L
    Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of total lymphocyte count for monitoring response to antiretroviral therapy.
    Schreibman T; Friedland G
    Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.
    Rajasekaran S; Jeyaseelan L; Vijila S; Gomathi C; Raja K
    AIDS; 2007 Jul; 21 Suppl 4():S47-53. PubMed ID: 17620752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
    Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
    Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
    Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
    Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting.
    Akinola NO; Olasode O; Adediran IA; Onayemi O; Murainah A; Irinoye O; Elujoba AA; Durosinmi MA
    Clin Infect Dis; 2004 Aug; 39(4):579-81. PubMed ID: 15356826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low sensitivity of total lymphocyte count as a surrogate marker to identify antepartum and postpartum Indian women who require antiretroviral therapy.
    Gupta A; Gupte N; Bhosale R; Kakrani A; Kulkarni V; Nayak U; Thakar M; Sastry J; Bollinger RC;
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):338-42. PubMed ID: 17846559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute lymphocyte count as surrogate for CD4+ cell count in monitoring response to antiretroviral therapy.
    Akanmu AS; Akinsete I; Eshofonie AO; Davies AO; Okany CC
    Niger Postgrad Med J; 2001 Sep; 8(3):105-11. PubMed ID: 11721211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.
    van der Ryst E; Kotze M; Joubert G; Steyn M; Pieters H; van der Westhuizen M; van Staden M; Venter C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):238-44. PubMed ID: 9803965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.